Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Hamann

Showing results (101-110 of 118) with videos related to

Pageof 12
Sort By:
Biochemical Pharmacology|January 24, 2023
Discovery of a novel, highly potent and orally bioavailable pyrrolidinone indole series of irreversible Myeloperoxidase (MPO) inhibitorsJean B Regard, Tyler J Harrison, Jake Axford, et al.
Journal of Medicinal Chemistry|March 23, 2018
Discovery of LSZ102, a Potent, Orally Bioavailable Selective Estrogen Receptor Degrader (SERD) for the Treatment of Estrogen Receptor Positive Breast CancerGeorge S Tria, Tinya Abrams, Jason Baird, et al.
Bioorganic & Medicinal Chemistry Letters|October 17, 2007
Potent non-nitrile dipeptidic dipeptidyl peptidase IV inhibitorsLigaya M Simpkins, Scott Bolton, Zulan Pi, et al.
Journal of Medicinal Chemistry|July 22, 2005
Discovery and preclinical profile of Saxagliptin (BMS-477118): a highly potent, long-acting, orally active dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetesDavid J Augeri, Jeffrey A Robl, David A Betebenner, et al.
Journal of Medicinal Chemistry|May 27, 2017
Design, Synthesis, and Properties of a Potent Inhibitor of Pseudomonas aeruginosa Deacetylase LpxCGrazia Piizzi, David T Parker, Yunshan Peng, et al.
Journal of Medicinal Chemistry|April 30, 2004
Synthesis of novel potent dipeptidyl peptidase IV inhibitors with enhanced chemical stability: interplay between the N-terminal amino acid alkyl side chain and the cyclopropyl group of alpha-aminoacyl-l-cis-4,5-methanoprolinenitrile-based inhibitorsDavid R Magnin, Jeffrey A Robl, Richard B Sulsky, et al.
Journal of Medicinal Chemistry|March 5, 2020
Discovery of CRBN E3 Ligase Modulator CC-92480 for the Treatment of Relapsed and Refractory Multiple MyelomaJoshua D Hansen, Matthew Correa, Mark A Nagy, et al.
Bioorganic & Medicinal Chemistry Letters|May 20, 2008
Pyridine amides as potent and selective inhibitors of 11beta-hydroxysteroid dehydrogenase type 1Haixia Wang, Zheming Ruan, James J Li, et al.
Journal of Medicinal Chemistry|April 9, 2009
N-aryl-oxazolidin-2-imine muscle selective androgen receptor modulators enhance potency through pharmacophore reorientationAlexandra A Nirschl, Yan Zou, Stanley R Krystek, et al.
Journal of Medicinal Chemistry|January 21, 2020
Discovery of a Brain-Penetrant ATP-Competitive Inhibitor of the Mechanistic Target of Rapamycin (mTOR) for CNS DisordersSimone Bonazzi, Carleton P Goold, Audrey Gray, et al.
Pageof 12

Showing results (101-110 of 118) with videos related to

Sort By:
Pageof 12
Biochemical Pharmacology|January 24, 2023
Discovery of a novel, highly potent and orally bioavailable pyrrolidinone indole series of irreversible Myeloperoxidase (MPO) inhibitorsJean B Regard, Tyler J Harrison, Jake Axford, et al.
Journal of Medicinal Chemistry|March 23, 2018
Discovery of LSZ102, a Potent, Orally Bioavailable Selective Estrogen Receptor Degrader (SERD) for the Treatment of Estrogen Receptor Positive Breast CancerGeorge S Tria, Tinya Abrams, Jason Baird, et al.
Bioorganic & Medicinal Chemistry Letters|October 17, 2007
Potent non-nitrile dipeptidic dipeptidyl peptidase IV inhibitorsLigaya M Simpkins, Scott Bolton, Zulan Pi, et al.
Journal of Medicinal Chemistry|July 22, 2005
Discovery and preclinical profile of Saxagliptin (BMS-477118): a highly potent, long-acting, orally active dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetesDavid J Augeri, Jeffrey A Robl, David A Betebenner, et al.
Journal of Medicinal Chemistry|May 27, 2017
Design, Synthesis, and Properties of a Potent Inhibitor of Pseudomonas aeruginosa Deacetylase LpxCGrazia Piizzi, David T Parker, Yunshan Peng, et al.
Journal of Medicinal Chemistry|April 30, 2004
Synthesis of novel potent dipeptidyl peptidase IV inhibitors with enhanced chemical stability: interplay between the N-terminal amino acid alkyl side chain and the cyclopropyl group of alpha-aminoacyl-l-cis-4,5-methanoprolinenitrile-based inhibitorsDavid R Magnin, Jeffrey A Robl, Richard B Sulsky, et al.
Journal of Medicinal Chemistry|March 5, 2020
Discovery of CRBN E3 Ligase Modulator CC-92480 for the Treatment of Relapsed and Refractory Multiple MyelomaJoshua D Hansen, Matthew Correa, Mark A Nagy, et al.
Bioorganic & Medicinal Chemistry Letters|May 20, 2008
Pyridine amides as potent and selective inhibitors of 11beta-hydroxysteroid dehydrogenase type 1Haixia Wang, Zheming Ruan, James J Li, et al.
Journal of Medicinal Chemistry|April 9, 2009
N-aryl-oxazolidin-2-imine muscle selective androgen receptor modulators enhance potency through pharmacophore reorientationAlexandra A Nirschl, Yan Zou, Stanley R Krystek, et al.
Journal of Medicinal Chemistry|January 21, 2020
Discovery of a Brain-Penetrant ATP-Competitive Inhibitor of the Mechanistic Target of Rapamycin (mTOR) for CNS DisordersSimone Bonazzi, Carleton P Goold, Audrey Gray, et al.
Pageof 12